Safety and Effectiveness Evaluation of Stent-Assisted Coil Embolization for Acute Ruptured Intracranial Aneurysms During the Perioperative Period

What this Trial Is About

Researchers are evaluating the safety and effectiveness of stent-assisted coil embolization for treating ruptured intracranial aneurysms during the acute phase. The study focuses on using intravenous antiplatelet drugs that are easy to administer and control, aiming to prevent rebleeding and aneurysm recurrence while examining complications and clinical outcomes in the perioperative period. Participants will undergo stent-assisted embolization of ruptured aneurysms, including remedial stent use when needed, within 7 days of the last hemorrhage. The study targets aneurysms with wide necks and includes patients with specific grades of severity. Intravenous antiplatelet drugs are administered postoperatively according to protocol to support treatment safety. During the study, participants will be monitored for surgical complications, ischemic and bleeding events, neurological function, and mortality within 30 days after surgery. Follow-up assessments include imaging to evaluate aneurysm occlusion immediately and one year after the procedure, functional scores at 30 days and one year, and detection of restenosis inside the stent. The total participation spans up to one year post-procedure, with safety and efficacy measures carefully tracked.

Safety and Efficacy Analysis of Stent-assisted Coil Embolization in the Treatment of Acute Ruptured Intracranial Aneurysms in the Perioperative Period.